Management of a patient of hypertriglyceridemia with Benign Prostate Hyperplasia through integrative medicine - A case report Authors: K Santhosh Published: 2024 ABSTRACT AbstractThis is a case report of a 60-year-old male, who was a patient of Benign Prostate Hyperplasia since 2019, diagnosed as having Hypertriglyceridemia (Serum Triglycerides-839 mg/dL) after routine screening in a Diagnostic Laboratory. Although these were two distinct disease entities, Charaka Samhita's concept of Srotas was taken into consideration for treatment, and drugs that reduced both Serum Triglyceride levels and Lower Urinary Tract Symptoms (LUTS) of BPH were chosen. Varanadi Kashaya and Shilajitvadi Bati were given as medicines and after one month of follow-up, Serum Triglycerides decreased to 283 mg/dL, and improvement in the form of reduction of hesitancy during urination was appreciated by the patient. Over the course of the next one and a half years, the patient's serum triglycerides level was monitored with the same two medicines, along with the addition of Vastyamayantaka Ghritam and improvement was seen at each follow-up appointment. Therefore, in people with obesity and disorders of urinary system, the medicines which act on the kidneys can be selected, since they serve as the common origin for Medovaha Srotas and Mutravaha Srotas.Keywords: Triglycerides, Obesity, Prostate, Ayurveda, Suryanamaskara Introduction The collective term for disorders of lipoprotein metabolism is “Dyslipidemias.” Clinically, Dyslipidemias are typically characterized by elevated plasma levels of cholesterol, triglycerides, or both, which are occasionally accompanied by decreased HDL cholesterol levels. In the majority, dyslipidemia patients have a mixture of genetic susceptibility (typically polygenic) and environmental factors (lifestyle, illness, or medication). The main factor leading to the diagnosis of dyslipidemia is that many, but not all, patients are at higher risk for Atherosclerotic Cardiovascular Disease (ASCVD). Patients with significantly increased triglyceride levels may also be at risk for developing Acute Pancreatitis. Patients who continue to have fasting TG levels above 500 mg/dL despite active lifestyle management are indicated for drug therapy. Three categories of medications are commonly used to treat these patients in modern medicine. They are fibrates, omega-3 fatty acids (fish oils), and niacin. Statins can also lower plasma TG levels and lower the risk of ASCVD [1]. In this case, because the patient was also a patient of BPH, the ideal treatment was to select medicines that would serve the purpose of reducing the level of triglycerides as well as give relief from the BPH symptoms. In a study on the Chinese population, the link between the TG/HDL-C and BPH is shown and male subjects with higher TG/HDL-C have the risk of developing BPH [2]. This is where the unique concept of Ayurveda, Srotas comes to the rescue. Srotas are the channels that carry tissues that are in the process of transformation. There are thirteen types of important channels like these in the body and each has its own origins at different sites in the body. One such channel is the Medovaha Srotas, the one that carries Medas (lipids). The causes of vitiation of this channel are lack of exercise, day sleep, excessive intake of fat-rich foods, and Varuni type of alcohol [3]. The resultant disease due to the vitiation of Medovaha Srotas, the application of this concept of Srotas, and one of the treatment options in Ayurveda for elevated TG levels are discussed further in this case report [4]. Patient information A 60-year-old man, who was previously a patient of Benign Prostate Hyperplasia, with significant post-void residue, was diagnosed as having Hypertriglyceridemia (Serum triglycerides-839 mg/dL) when he went for routine screening in a diagnostic laboratory, as per the advice of his physician. He was a vegetarian, non-smoker, non-alcoholic, and someone who regularly exercised in the morning. An accountant by profession, the man was found to have Grade 1 Prostatic enlargement with significant post-void residue of 70 ml on 12 March 2019. The man was neither diabetic nor hypertensive and was not taking any medications before the diagnosis of Grade 1 Benign Prostate Hyperplasia. He was advised by his physician to take Prosteez (Charak Pharma) and Fortege (Alarsin Pharmaceuticals), one tablet each, twice daily because of which his LUTS (Lower Urinary Tract Symptoms) were under control. He was on both these tablets for almost two and a half years (till 21 October 2021). The person mostly ate South Indian food and none of his family members had BPH, obesity issues or any other morbidity. He has a medium height of 5.5 feet and weighs 74 Kg with a Waist circumference of 40 inches and a Hip circumference of 39 inches. His Waist-to-Hip ratio was 1.03. Clinical findings The patient was afebrile. Pulse was 70 bpm, Blood Pressure was 120/80 mm Hg and BMI was found to be 26.3 kg/m2. The Respiratory, Cardiovascular, and Central Nervous Systems had no abnormalities. The patient had a pear-shaped abdomen and the abdominal examination revealed a soft and non-tender abdomen with normal BS (Bowel Sounds). On Digital Rectal Examination (DRE), the upper limit of the Prostate was accessible. There were no signs of Xanthelasma, Xanthomas, etc. on the skin. Timeline Timeline.TimepointEvents21 October 2021Diagnosed as Hypertriglyceridemia based on Lipid Profile Value (Serum Triglycerides-839 mg/dL)22 October 2021–21 November 2021Varanadi Kashaya and Shilajitvadi Bati were administered. Tablet Prosteez and Tablet Fortege were discontinued.22 November 2021First Serum Triglycerides test was done22 November 2021–11 January 2022Shilajitvadi Bati alone was administered12 January 2022The second Serum Triglycerides test was done.12 January 2022–24 May 2022Shilajitvadi Bati alone was administered25 May 2022Lipid Profile and Thyroid Profile were done.25 May 2022–20 February 2023Vastyamayantaka Ghrita (Kottakal), Varanadi Kashaya and Shilajitvadi Bati were administered.20 Feb 2023Lipid Profile was done. Timeline. Diagnostic assessment The condition was diagnosed as Hypertriglyceridemia based on the Serum Triglyceride value in the Lipid Profile. During the second and third visits, only the Serum Triglycerides test was advised. The condition of Hypertriglyceridemia was correlated to Sthaulya for the reason that Hypertriglyceridemia is a form of Dyslipidemia and all the anomalies of lipid breakdown can be studied under the broader heading of Sthaulya [4]. The differential diagnosis is Chylomicronemia. Laboratory investigations The Lipid Profile findings were as follows: Total Cholestrol-255 mg/dL, Serum Triglyceride-839 mg/dL, HDL Cholesterol (Direct)-25 mg/dL, LDL Cholesterol (Direct)-57.22 mg/dL, CHOL/HDL Ratio (Calculated)-10, LDL/HDL Ratio (Calculated)-2.3 mg/dL. The Fasting Blood Sugar was 97 mg/dL and TSH (CLIA) was 3.130 mcIU/ml. The USG scan of the Abdomen and Pelvis showed mild Prostatomegaly with post-void residue of 90 ml. Ashtasthana Pareeksha (Eight-fold examination) Nadi: Rajahamsavat (Like a swan) Nadi: Rajahamsavat (Like a swan) Mutra: Saphena (frothy) Mutra: Saphena (frothy) Mala: Kapisha (Brown) Mala: Kapisha (Brown) Jihwa: Rakta (Pink) Jihwa: Rakta (Pink) Shabda: Guru (Bass voice) Shabda: Guru (Bass voice) Sparsha: Ardra (Moist) Sparsha: Ardra (Moist) Drik: Snigdha (unctuous) Drik: Snigdha (unctuous) Akriti: Goodha, Snigdha, Shlishta Sandhi (Joints are deep, unctuous and freely moving without crepitus) Akriti: Goodha, Snigdha, Shlishta Sandhi (Joints are deep, unctuous and freely moving without crepitus) DashavidhaPareeksha (Ten-fold examination) Prakriti: Kapha-Pittala Prakriti: Kapha-Pittala Vikriti: Kaphaja Vikriti: Kaphaja Saara: Madhyama Saara: Madhyama Samhanana: Madhyama Samhanana: Madhyama Pramana: Prostate measures 35 mm × 32 mm × 41 mm. Bladder base indentation-5mm (USG scan) Pramana: Prostate measures 35 mm × 32 mm × 41 mm. Bladder base indentation-5mm (USG scan) Satmya: Sarvarasa Satmya Satmya: Sarvarasa Satmya Satva: Madhyama Satva: Madhyama Aharashakti: Abhyavaharana Shakti-Pravara; Jarana Shakti-Pravara Aharashakti: Abhyavaharana Shakti-Pravara; Jarana Shakti-Pravara Vyayamashakti: Pravara Vyayamashakti: Pravara Vaya: Vriddha Vaya: Vriddha Therapeutic intervention Oral medication (Depicted in Table 1) and 12 rounds of Suryanamaskara in the morning were adopted as treatment in this case. The patient was advised to restrict the intake of Maida (Refined Wheat Flour) products like biscuits, bread, etc. Table 1Therapeutic intervention in the present case.Table 1Mode of treatmentMedicineAnupanaDoseTimeDurationOral medicationVaranadi Kashaya (Ashtanga Hridaya. Sutrasthana. 15/22)Water (Equal quantity)15 mlMorning and night, before food22 Oct 2021 to 21 Nov 2021 (31 days) and 25 May 2022 to 20 Feb 2023 (272 days).Shilajitvadi Bati (Siddhayog Sangraha)Water1 tabletMorning and night, after food22 Oct 2021 to 20 Feb 2023 (487 days).Vastyamayantaka Ghritam (Sahasrayoga. Ghrita Prakarana. 29)Warm water10 mlMorning, on an empty stomach25 May 2022 to 20 Feb 2023 (272 days) Therapeutic intervention in the present case. Follow-up and outcome The changes in the parameters after one month of treatment is depicted in Table 2. Table 2Showing the changes in the parameters from first visit to the fifth visit.Table 2ParametersDuring first visit (21 Oct 2021)During second visit (22 Nov 2021)During third visit (12 Jan 2022)During fourth Visit (25 May 2022)During fifth Visit (20 Feb 2023)Weight74 kg70 kg69 kg71 kg68 kgWaist circumference40 inches38 inches37 inches39 inches36 inchesHip circumference39 inches38.5 inches38 inches38.5 inches37.5 inchesWaist-to-Hip ratio1.030.990.971.010.96BMI26.3 kg/m2 (Overweight)24.9 kg/m2 (Normal)24.6 kg/m2 (Normal)25.3 kg/m2 (Overweight)24.2 kg/m2 (Normal) Showing the changes in the parameters from first visit to the fifth visit. The combination of Varanadi Kashaya and Shilajitvadi Bati decreased Serum Triglyceride value by 66% (from 839 mg/dL to 283 mg/dL) in one month during 2nd visit. The change in Serum Triglycerides value during further visits is depicted in Table 3. The Prostatomegaly was Grade 1 in the impression of the USG report of the Abdomen and Pelvis from the first visit (21 October 2021) to the fifth visit (20 February 2023). The patient employed technology as a steadfast ally, utilizing Google Keep for medication reminders and a Loop Habit Tracker app to diligently record daily sessions of Suryanamaskara. This combination of digital tools not only helped him take his medication on time but also gave him a clear record of his regular commitment to Suryanamaskara. The patient's son has also contributed to strengthening and guaranteeing regular adherence to medication and Suryanamaskara. Also, there were no issues related to the tolerability and palatability of the formulations. The adverse events were also not reported. Table 3Showing the Serum Triglycerides level on the first visit and other visits.Table 3Lipid ProfileFirst Visit (21 Oct 2021)Second Visit (22 Nov 2021)Third Visit (12 Jan 2022)Fourth Visit (25 May 2022)Fifth Visit (20 Feb 2023)Cholestrol255 mg/dL--239 mg/dL238 mg/dLSerum Triglyceride839 mg/dL283 mg/dL255 mg/dL391 mg/dL168 mg/dLHDL Cholestrol (Direct)25 mg/dL––28 mg/dL39 mg/dLLDL Cholestrol (Direct)57.22 mg/dL––131.26 mg/dL159 mg/dLCHOL/HDL Ratio (Calculated)10––96LDL/HDL Ratio (Calculated)2.3––4.74.1 Showing the Serum Triglycerides level on the first visit and other visits. Discussion When evaluating a serum triglyceride level of 839 mg/dL, the first factor to rule out is the family history. Since there were no known complaints of obesity or dyslipidemia in the family, genetic factors contributing to the elevated triglyceride levels were ruled out. As far as medical history is concerned, there was no prior diagnosis of diabetes, and his FBS was well within the normal range. Additionally, he did not use medications associated with hypertriglyceridemia, such as corticosteroids, estrogens, antipsychotics, or immunosuppressants. However, he had been consistently taking Prosteez and Fortege tablets for a duration of two and a half years. Saw Palmetto, a key ingredient in Prosteez, has been implicated in drug-induced pancreatitis in documented cases [5], although its impact on serum triglycerides remains uncertain. Elevated triglyceride levels, typically at 500–1000 mg/dL, can increase pancreatitis risk due to pancreatic lipase activity. However, the absence of symptoms and normal imaging ruled out acute conditions. The possibility of chylomicronemia was dismissed as its characteristic triglyceride levels typically exceed 1000 mg/dL, distinguishing it from hypertriglyceridemia. Hence, the treatment focused on hypertriglyceridemia, attributed to lifestyle factors, guided by an endocrinologist's recommendation. In the present case, because the patient was already a patient of BPH, a disorder of the Urinary system, there was a need to find a treatment, which would manage both BPH and Hypertriglyceridemia. Here, Hypertriglyceridemia was correlated to Sthaulya (∼obesity), a disease due to Medovaha Sroto Dushti (∼vitiation of the channels carrying lipids) for the reason that all obesity-related issues are studied under the heading of Sthaulya. On the other hand, BPH, being a condition of the Urinary system, is considered a disease due to Mutravaha Sroto Dushti (∼vitiation of the channels carrying urine). The common origin for both Medovaha Srotas and Mutravaha Srotas is the Kidneys and the treatment was planned, keeping the Kidneys as the main focus. Therefore, Varanadi Kashaya (Ashtanga Hridaya. Sutrasthana. 15/22) and Shilajitvadi Bati (Siddhayog Sangraha) were selected as the oral medicines in the present case. Varanadi Kashaya, indicated in Antar Gulma (tumors inside the body), is a polyherbal formulation with 16 herbs [6]. One of the symptoms of Antar Gulma/Abhyanatara Gulma is pain in the Basti (∼Pelvic region) and Kukshi (∼Abdomen), hinting at bladder and abdominal pain common in Bladder Outlet Obstruction (BOO) in BPH patients [7]. It is also used for Medodosha (∼Obesity and Atherosclerosis) [6]. Crataeva nurvala (Varuna), which is one of the main ingredients in Varanadi Kashaya, is also found to be nephroprotective in 2K1C rats [8]. Whereas, Shilajitvadi Bati (Siddhayog Sangraha) was selected for the treatment because of its common usage in clinical practice for Mutra Krichhra (Urinary retention). The ingredients of Shilajitvadi Bati like Shilajitu (Asphaltum), and Gudmar (Gymnema Sylvestre) leaves have also shown lipid-lowering activity [9,10]. This indicates that both medicines have their action on both Mutravaha Srotas and Medovaha Srotas. To prevent Vata aggravation from prolonged Kashaya use, the patient was solely administered Shilajitvadi Bati from November 22, 2021, to May 24, 2022. During this period, Serum Triglycerides increased to 391 mg/dL, likely due to a 4-month gap before the fourth visit, coinciding with the patient's attendance at several social gatherings, possibly leading to heightened carbohydrate intake. The rise in Serum Triglycerides suggested that Shilajitwadi Bati alone wasn't enough to treat Hypertriglyceridemia. Since Vastyamayanthaka Ghritam, a medicated Ghee, was introduced after the fourth visit (May 25, 2022), concerns regarding Vata aggravation were alleviated since it can create unctuousness in the body. Consequently, Varanadi Kashaya was reintroduced to improve the efficacy in reducing Serum Triglyceride levels, yielding noticeable results. The rationality behind adding Vastyamayanthaka Ghritam is that it is known to ensure the unobstructed passage of urine thereby contributing to the reduction of LUTS symptoms in BPH [11]. Despite its addition, Serum triglyceride levels remained stable in the Lipid Profile during the fifth visit (February 20, 2023). Varanadi Kashaya and Shilajitvadi Bati are safe to use for the longer term and 66% reduction in Serum Triglycerides level in a span of one month is the biggest positive from this case and is a great hope for those who seek Ayurveda as the primary treatment. Vamana, a Panchakarma, was also advised for the patient but he did not give his consent for the same. Three categories of medications like fibrates, omega-3 fatty acids (fish oils), and niacin are commonly used to treat these patients in modern medicine. Statins can also lower plasma TG levels, lower the risk of ASCVD and are safe for the long term [1]. Since the patient was unwilling to take modern medicines for treatment, he was advised oral therapy with Varanadi Kashaya and Shilajitvadi Bati. The use of Kashayas is known to cause Rookshata in the Dhatus and the symptoms that could be expected are Alpa Mutrata which would again aggravate LUTS. Also, considering the age of the patient it was ideal to compensate for this by Snigdhata of Vastyamayantaka Ghrita. Additionally, the patient's regular Yoga practice, including Suryanamaskara, was encouraged, as it plays a significant role in managing body weight and positively impacting blood lipid profiles. Incorporating Yogic practices has been linked to increased HDL levels and decreased concentrations of very low-density lipoprotein cholesterol and triglycerides [12]. Basti administration is also planned for future visits. Conclusion The integrative approach utilizing Varanadi Kashaya, Shilajitvadi Bati, Vastyamayanthaka Ghrita and Suryanamaskara has shown promising results in addressing both hypertriglyceridemia and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). By effectively targeting the underlying mechanisms related to lipid metabolism and urinary system function, this treatment regimen offers a holistic approach to managing these concurrent conditions. Further research with larger sample sizes would be beneficial to validate the efficacy and safety of this approach and to explore its long-term effects on pancreatitis prevention, cardiovascular health, and overall quality of life for individuals with hypertriglyceridemia and BPH. Patient perspective “I come from an orthodox family with traditional values. My grandmother was a folklore practitioner. From pain, and fever to any kinds of diseases, we always seek Ayurveda treatment. I regularly visit my family physician who also happens to be a BAMS and an integrated practitioner once in 6 months for a routine check-up because I am also a patient of BPH for which he advises to get a few lab tests and a USG scan done. After the lipid profile was out, my doctor told me that my serum triglyceride level was very high and it was ideal for me to start Atarvostatin. Since I was not a fan of modern medicine, I visited an Ayurveda doctor whom my friend suggested. He advised me to take Varanadi Kashaya and Shilajitwadi Bati with Suryanamaskara in the morning for one month and visit him later. After a month of taking medicines, I got my lab tests done and to my surprise, my serum triglycerides were reduced to an extent, more than what I was told. I thanked the doctor for this and requested him to publish this as an article so that it would help so many people like me who are looking for a cure in Ayurveda.” Source of funding None. Author contributions SK- Conceptualization, Methodology, Validation, Resources, Writing-original draft, Writing-review & editing. Declaration of generative AI in scientific writing During the preparation of this work, the author used Paraphrasing tool-Quillbot AI in order to paraphrase. After using this tool/service, the author reviewed and edited the content as needed and takes full responsibility for the content of the publication. Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgment None. Footnotes Peer review under responsibility of Transdisciplinary University, Bangalore. Supplementary data to this article can be found online at https://doi.org/10.1016/j.jaim.2024.100991. Supplementary data The following are the supplementary data to this article: Multimedia component 1 References Associated Data Supplementary Materials Multimedia component 1